Jason Wu is currently a portfolio manager at Optimization Asset Management LLC, a Long/Short hedge fund based in the U.S. Dr. Wu spent seven years as a quantitative strategist/portfolio manager at Perry Capital, an event driven hedge fund, where he managed quantitative strategies. Jason Wu also developed the risk management system and other quantitative price models for the company during a period when Perry’s asset under management grew from $1 billion to $8 billion. Prior to working at Perry Capital, Dr. Wu spent 5 years as a quantitative analyst at General Re, CDC Capital and Bankers Trust. Jason Wu has a Ph.D. in physics from Yale University and Bachelor of Science from Tsinghua University, Beijing, China.
My career has been as a research scientist. My background is Physics/Engineering/Aerospace, and my recent work is in burn modifiers for DOD propellants and agent defeat additives for DHS.
As a landlord I'm a real estate investor/developer with a number of buildings in NJ and ME.
I'm also very active in securities, trading regularly, with a significant exposure in the options market. My primary discipline in the markets is that of "Chartist", or Technical Analysis. I've been trading for over 15 years, and have gone through the gamut of technical indicators over the years and have now settled on what I euphemistically call the "C-Fold" technique, as it requires a C-Fold towel to execute. I primarily trade trends now, seeking to enter long and short positions to maximize my return from any given trend that I identify.
I was also a member of the Worden Brothers Roundtable of Knights when I was using the Worden Brothers TC2000 software for doing my TA.
I am in the process of starting a blog which will have regular chart analysis of various securities that I find interesting. In the meantime, you can find commentary and charts on my facebook page: http://www.facebook.com/vern.hoffmann.3?ref=tn_tnmn
Finished CFA level 1 & CAIA level 1 in a breeze. Looking forward to CAIA level 2 and CFA level 2. Made top 1% on the Bloomberg BAT, but was a black sheep at my mediocre college, and I was foolish to let it affect me. (non-traditional student)
Hope to write some quality articles in the coming year.
I was playing with fire my first year in the market, using a lot of call options. It was easy to make 50+% gain in 1st yr, summer '13 to summer '14 (thank you bull mkt). This past half year has been a little rough; I wish I had acted more decisively on material information about the energy market and the movement of the Ruble ($YNDX is a favorite).
I remember announcing the probably course of events to family the morning after OPEC's Thanksgiving's Day announcements, and I regrettably decided to wait it through b/c our professors chided us to take a buy and hold approach, and b/c I had bought some quality energy names at very fair prices in October. In retrospect, I realize the importance of optionality or in a sense, degrees of freedom.
In this case, I realize I am too committed to a base scenario (energy stocks recovering in the next year) that has too much opportunity cost. If the price adjustment cycle lasts longer than the expected scenario, then I will be unhappy with the opportunities lost. An equal weight short position would have been an ideal temporary maneuver, expressing my short-term thesis, while not causing commitment angst in the present, hoping for the long-term adjustment to blow over.
I was entrusted with a fresh 100K family capital this past summer, and I plan to be more prudent and thorough (obviously with minimal leverage or derivatives). This market is a little dangerous with high debt loads in China, somewhat high valuation levels (horrible Schiller CAPE ratio, but not sure if that matters as much), and jitters over rate hike, Ukraine, terrorism, epidemics, difficulty of private sector adjusting to Obamacare, and possible fiscal & monetary stimulus tapering.
I think low energy prices is a great stimulus, but the possibilities of a perfect storm with semi-hard landing in China or Europe, a serious violent flare-up with Russia or the Terror War, and disease outbreak could somehow happen at just the wrong time (perhaps, right after a rate hike).
I've read a fair amount of Buffett. But I love the tech industry mostly. To humor Buffett (a tech dinosaur), I bought a tiny bit of IBM. It has been working hard to transform its whole business, and actually has some top-notch talent and product portfolios with a fairly conservative valuation. The market is probably right that is a long-shot that IBM will grow significantly again, despite its immense technology assets and partnerships. Recent comment: feel lucky to have exited IBM at a small gain; mulling a re-entry and annoyed that I missed the recent Google explosion. Google is solidifying its reach and ecosystem, but at steep multiples.
I've been away from investing for much of the past half year (now dec'15), partly because I was getting cyberattacks on my twitter account, my computer, and broker connection was being intercepted, which made me very uncomfortable. My car also very suddenly needed an engine replacement that same week, despite a thorough check-up a month prior. I'm having a hard time moving forward, after severe blacklisting after-effects, (too long & weird to discuss).
CAIA & CFA level 1s were super-easy even though I was underprepared. I look forward to embracing the challenge. I will end up working in Europe or abroad, if I have to. Lucky to get tons of invites from Bloomberg recruitment due to top notch scores, but haven't really applied b/c of crummy school issues. Plan to work on Wall Street Prep & hopefully some SA articles.
Dreamjob: working for a hedge fund focussing in equities, preferably with a multicultural bunch (I'm half european / half asian american)
Long-term dream job: top-notch hedge fund manager
My favorite time horizon: 3mo to 18mo, b/c best chance of having a direct connect with news & analysis. market moves too fast to be primarily buy & hold, albeit such a mid-term outlook forfeits the benefit of effective interest-free loan in the the form of deferred taxes (as Buffett makes use of) as well as benefit of a capital gains rate, but on the other hand, a mid-term outlook maximizes flexibility. I'm trying to stay more grounded in fundamentals, flesh out the invest case for a quite a handful of stocks, and balancing risks in wide portfolio. Plan to explore ETF's more.
I am teaching and doing research in mathematics at University Paris 12. I have a PhD in Dynamical Systems from the University of Orsay.My main hobbies are investing, programming, playing pool, parenting and playing backgammon.I am co-founder of a startup which helps institutions digitize and organize paper documents. We hope to complete an OCR software developed in house that will allow indexing scanned books.
I am a physician and attorney (UChicago '88) who became interested in finance somewhat later in life. Prior to this, worked briefly for large (>700 atty) law firm. I very much appreciate the postings here-- the articles, commentary, etc --- that I utilize to think and study from on a host of topics that interest me. I am considering registering for an online MA in finance from a non-profit business school for the fun of it. Advice? Presently I am enrolled in challenging online investor education program that has been an enormous help in understanding the various markets --- but alas, I'm not someone who was introduced to this world at age 13 by my parents. Would appreciate comments anyone has about "must-read books" and other cues.
I am an individual investor, who takes pride in analyzing companies in detail by combining qualitative analysis's with quantitative models.
To optimize my models, I read read everything I can about the company. This includes, annual- and quarterly reports, earnings call transcripts and general news.
When I am not analyzing or writing about stocks, I am studying for my MSc in Finance/Economics
Andrew McDonald is a healthcare investment professional with expertise in identifying transformative medicines as well as in forecasting clinical trial, regulatory, and sales outcomes. Prior to co-founding LifeSci Advisors, Andrew most recently served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund. From 2004-2006, Andrew was Co-head of Healthcare Research and Biotechnology Analyst at ThinkEquity Partners, a boutique investment bank. Prior to entering the financial services industry, Andrew was a medicinal chemist at Cytokinetics from 2001-2004, where he discovered and developed a promising anti-cancer agent now in clinical trials. Andrew began his pharmaceutical career as a medicinal chemist at Pfizer from 2000-2001. Andrew received a Ph.D. in organic chemistry from UC Irvine and completed his B.S. in chemistry at UC Berkeley.
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter. He is on the Advisory Board of NY Residential REIT and he is a shareholder and publisher on TheMaven (MVEN).
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, CNN, Newsmax, and Fox. He is the #1 contributing analyst on Seeking Alpha in 2014, 2015, and 2016 (based on page views).
Thomas has co-authored a book, The Intelligent REIT Investor, and is the author of The Trump Factor: Unlocking The Secrets Behind The Trump Empire (available on Amazon).
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College and he is also on the Advisory Board of the Donald J. Trump Presidential campaign.